EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Simple and Accurate LC–MS/MS Method for the Determination of Indobufen in Human Plasma and Its Clinical Application

Hongyan Ji iD, Haijun Qu iD, Qie Guo iD, Donghua Liu, Changli Xu, Xue Yang, Fanbo Jin iD, Wen Xu iD

Journal of Analytical Methods in Chemistry · 2026-01 · 2026 (1)

DOI: 10.1155/jamc/2232924 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Analytical Methods in Chemistry, online erschienen am 28.07.2026. Verfasst von Hongyan Ji und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The Affiliated Hospital of Qingdao University, Qingdao 266003, Shandong, China, qdu.edu.cn. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As an antithrombotic agent, indobufen is widely used in China. However, the relationship between drug concentration and therapeutic efficacy in specific patient populations remains unclear. Therefore, it is crucial to establish a method for quantifying indobufen concentrations in human plasma to guide dosage recommendations. An electrospray ionization (ESI) power supply was utilized in conjunction with multireaction monitoring (MRM) in positive ion mode. Protein precipitation was employed to extract indobufen from the plasma sample. Separation was carried out using a ChromCORE‐C18 column with a gradient elution of the mobile phase, which was composed of 0.1% formic acid in water (Solvent A) and methanol (Solvent B) at a flow rate of 0.3 mL/min. The typical standard curve equation was Y = 0.763 X + 0.0986 ( r = 0.9993), demonstrating a good linear relationship within the range of 0.5–30 μg/mL. All methodological outcomes complied with regulatory guidelines. In patients with moderate renal insufficiency, it is advisable to reduce the dosage to 100 mg once daily. For patients with severe renal insufficiency, the dosage should be reduced to 1/3–1/4 of the standard dose. For patients undergoing continuous renal replacement therapy (CRRT), indobufen can be gradually eliminated, and most patients do not require dose adjustment.

Schlagwörter

Stichwörter der Autor:innen

CRRTLC–MS/MSindobufenrenal insufficiency

Autor:innen und Institutionen

  • Department of Pharmacy, The Affiliated Hospital of Qingdao University, Qingdao 266003, Shandong, China, qdu.edu.cn.
  • Department of Cardiovascular Surgery, The Affiliated Hospital of Qingdao University, Qingdao 266003, Shandong, China, qdu.edu.cn.

ORCID-Profile: Hongyan Ji, Haijun Qu, Qie Guo, Fanbo Jin, Wen Xu

Förderung

  • Natural Science Foundation of Shandong Province

Zitieren

APA

Ji, H., Qu, H., Guo, Q., Liu, D., Xu, C., Yang, X., Jin, F., & Xu, W. (2026). A Simple and Accurate LC–MS/MS Method for the Determination of Indobufen in Human Plasma and Its Clinical Application. Journal of Analytical Methods in Chemistry, 2026(1). https://doi.org/10.1155/jamc/2232924

Vancouver

Ji H, Qu H, Guo Q, Liu D, Xu C, Yang X, et al. A Simple and Accurate LC–MS/MS Method for the Determination of Indobufen in Human Plasma and Its Clinical Application. Journal of Analytical Methods in Chemistry. 2026;2026(1). doi:10.1155/jamc/2232924

BibTeX
@article{Ji2026,
  author = {Ji, Hongyan and Qu, Haijun and Guo, Qie and Liu, Donghua and Xu, Changli and Yang, Xue and Jin, Fanbo and Xu, Wen},
  title = {A Simple and Accurate LC–MS/MS Method for the Determination of Indobufen in Human Plasma and Its Clinical Application},
  journal = {Journal of Analytical Methods in Chemistry},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/jamc/2232924}
}
Kostenlos starten →